Effect of Covid-19 on Different Countries: A Comprehensive Review

Main Article Content

RAJENDRA KUMAR JADI
Keerthi Reddy Pannala
Prathyusha Peruri
Satwika Pendem
Sowmya Panjala
Vasudha Bakshi

Abstract

Coronavirus disease 2019 (COVID-19) was first distinguished in China in December 2019 and proclaimed as a pandemic by the World Health Organization (WHO) on March 11, 2020. The clinical qualities of the sickness range from asymptomatic cases or gentle manifestations, which incorporate vague indications like fever, headache, sore throat, cerebral pain, and nasal clog to extreme cases like pneumonia, respiratory failure requesting mechanical ventilation to multi-organ failure, sepsis, and death. Scientists have detailed that the infection is continually advancing and spreading through asymptomatic transporters, further recommending a high worldwide global threat. Keeping up with hand-cleanliness, social distancing, and individual defensive hardware (i.e., covers) stay the best safeguards. Patient administration incorporates steady consideration and anti-coagulated measures, with an emphasis on keeping up with respiratory capacity. Treatment with Dexamethasone, Remdesivir, and Tocilizumab seem, by all accounts, to be generally encouraging. In this review, we have discussed the effect of covid-19 in different countries during the first wave and second wave, the positivity rate, and the mortality rate. We have also discussed the covid-19 pandemic effect on the unemployment and education system, the medications, and treatment during the first wave and second wave. The review also focuses on the recent threat of fungal disease, Mucormycosis.

Article Details

How to Cite
JADI, R. K., Pannala, K. R. ., Peruri, P. ., Pendem, S. ., Panjala, S. ., & Bakshi, V. . (2022). Effect of Covid-19 on Different Countries: A Comprehensive Review. International Journal of Pharmaceutical and Bio Medical Science, 2(10), 390–399. https://doi.org/10.47191/ijpbms/v2-i10-02
Section
Articles

References

I. Ali, I. (2020). COVID-19 : Are We Ready for the Second Wave ?2019, 2020–2022. https://doi.org/10.1017/dmp.2020.149

II. Asrani, P., Eapen, M. S., Hassan, I., & Sohal, S. S. (2021). Implications of the second wave of COVID-19 in India. The Lancet Respiratory, 9(9), e93–e94. https://doi.org/10.1016/S2213-2600(21)00312-X

III. Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., Lopez de Castilla, D., Finberg, R. W., Dierberg, K., Tapson, V., Hsieh, L., Patterson, T. F., Paredes, R., Sweeney, D. A., Short, W. R., … Lane, H. C. (2020). Remdesivir for the Treatment of Covid-19 — Final Report. New England Journal of Medicine, 383(19), 1813–1826.

https://doi.org/10.1056/nejmoa2007764

IV. Bontempi, E. (2020). The Europe second wave of COVID-19 infection and the Italy “strange” situation. Environmental Research, 110476. https://doi.org/10.1016/j.envres.2020.110476

V. Hamlet, A., Djafaara, B. A., Cucunubá, Z., Mesa, D. O., Green, W., Thompson, H., Nayagam, S., Ainslie, K. E. C., Bhatia, S., Bhatt, S., Boonyasiri, A., Boyd, O., Brazeau, N. F., Cattarino, L., Cuomo-dannenburg, G., Dighe, A., Donnelly, C. A., Dorigatti, I., Elsland, S. L. Van, … Ghani, A. C. (2020). The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. 422(July), 413–422.

VI. Lone, S. A., & Ahmad, A. (2020). COVID-19 pandemic – an African perspective. https://doi.org/10.1080/22221751.2020.1775132

VII. Patel, U., Shah, D., Pinto, C., Suprun, M., Hennig, N., & Sacks, H. (2020). Early epidemiological indicators , outcomes , and interventions of COVID-19 pandemic : A systematic review. 10(2), 1–15. https://doi.org/10.7189/jogh.10.020506

VIII. Shi, Y., Wang, G., Cai, X. peng, Deng, J. wen, Zheng, L., Zhu, H. hong, Zheng, M., Yang, B., & Chen, Z. (2020). An overview of COVID-19. Journal of Zhejiang University: Science B, 21(5), 343–360. https://doi.org/10.1631/jzus.B2000083

IX. Varma, P., Junge, M., Meaklim, H., & Jackson, M. L. (2021). Progress in Neuropsychopharmacology & Biological Psychiatry Younger people are more vulnerable to stress , anxiety and depression during COVID-19 pandemic : A global cross-sectional survey. Progress in Neuropsychopharmacology & Biological Psychiatry, 109(December 2020), 110236. https://doi.org/10.1016/j.pnpbp.2020.110236

X. Wu, Y., Jing, W., Liu, J., Ma, Q., Yuan, J., Wang, Y., Du, M., & Liu, M. (2020). Science of the Total Environment Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries. 729, 1–7. https://doi.org/10.1016/j.scitotenv.2020.139051

XI. Yuki, K., Fujiogi, M., & Koutsogiannaki, S. (2020). COVID-19 pathophysiology: A review. Clinical Immunology, 215(April). https://doi.org/10.1016/j.clim.2020.108427